GenVec Reviews

Recommend to a friend
Approve of CEO
GenVec President, CEO, and Director Paul H. Fischer
Paul H. Fischer
3 Ratings
  • Friendly

    • Work/Life Balance
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at GenVec

    Approves of CEO
    Approves of CEO


    Friendly coworkers and easy pace.


    slow pace and often not focused

GenVec Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters Gaithersburg, MD
Size 16 to 50 Employees
Founded Unknown
Type Company - Public (GNVC)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year
Competitors Novartis, Sanofi-Aventis

GenVec is all over the medical map. The clinical-stage biopharmaceutical firm develops gene-based drugs and vaccines for everything from cancer to HIV. GenVec has multiple vaccine candidates for contagious diseases, such as HIV, malaria, and foot-and-mouth, through grants and partnerships with several federal agencies including the US departments of Health and Human Services, Homeland Security, and Agriculture. The company's other drug research and development programs target cancers and hearing and balance disorders, mostly through collaborations with other drugmakers.

Work at GenVec? Share Your Experiences


Click to Rate